Nostos Genomics

The company provides an AI-driven variant interpretation platform called AION designed for genetic testing labs and medical institutes. The software automates the identification and classification of pathogenic variants in genomic sequencing data, specifically for rare disease diagnostics. It generates automated reports and decision-support insights with a focus on reducing the interpretation bottleneck for exome and trio analysis.